Dexxos Participações Toekomstige groei
Future criteriumcontroles 1/6
Dexxos Participações is forecast to grow earnings and revenue by 5.4% and 14.6% per annum respectively while EPS is expected to grow by 6% per annum.
Belangrijke informatie
5.4%
Groei van de winst
6.0%
Groei van de winst per aandeel
Chemicals winstgroei | 56.2% |
Inkomstengroei | 14.6% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 09 Aug 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2025 | 2,123 | 177 | N/A | 207 | 1 |
12/31/2024 | 2,005 | 162 | N/A | 170 | 1 |
6/30/2024 | 1,660 | 165 | 177 | 246 | N/A |
3/31/2024 | 1,664 | 176 | 240 | 275 | N/A |
12/31/2023 | 1,745 | 181 | 315 | 340 | N/A |
9/30/2023 | 1,801 | 160 | 324 | 352 | N/A |
6/30/2023 | 1,840 | 148 | 313 | 345 | N/A |
3/31/2023 | 1,953 | 137 | 186 | 227 | N/A |
12/31/2022 | 2,098 | 150 | 159 | 202 | N/A |
9/30/2022 | 2,178 | 134 | 36 | 85 | N/A |
6/30/2022 | 2,182 | 173 | -17 | 38 | N/A |
3/31/2022 | 2,043 | 210 | -35 | 16 | N/A |
12/31/2021 | 1,774 | 192 | -100 | -48 | N/A |
9/30/2021 | 1,494 | 197 | -38 | 6 | N/A |
6/30/2021 | 1,328 | 151 | -47 | -16 | N/A |
3/31/2021 | 1,109 | 148 | 62 | 87 | N/A |
12/31/2020 | 995 | 119 | 93 | 116 | N/A |
9/30/2020 | 915 | 98 | 92 | 102 | N/A |
6/30/2020 | 842 | 88 | 87 | 109 | N/A |
3/31/2020 | 848 | 28 | -1 | 25 | N/A |
12/31/2019 | 798 | 25 | -22 | 1 | N/A |
9/30/2019 | 794 | 29 | -1 | 31 | N/A |
6/30/2019 | 769 | 23 | -24 | -2 | N/A |
3/31/2019 | 728 | 8 | -25 | -6 | N/A |
12/31/2018 | 735 | 7 | -6 | 11 | N/A |
9/30/2018 | 679 | 88 | -79 | -69 | N/A |
6/30/2018 | 613 | 89 | -46 | -38 | N/A |
3/31/2018 | 561 | 91 | N/A | -5 | N/A |
12/31/2017 | 484 | 81 | N/A | -9 | N/A |
9/30/2017 | 445 | 61 | N/A | 61 | N/A |
6/30/2017 | 433 | 41 | N/A | 48 | N/A |
3/31/2017 | 438 | 47 | N/A | 40 | N/A |
12/31/2016 | 438 | 53 | N/A | 39 | N/A |
9/30/2016 | 437 | -25 | N/A | 34 | N/A |
6/30/2016 | 428 | -28 | N/A | 39 | N/A |
3/31/2016 | 411 | -38 | N/A | 32 | N/A |
12/31/2015 | 398 | -41 | N/A | 36 | N/A |
9/30/2015 | 390 | -23 | N/A | 23 | N/A |
6/30/2015 | 376 | -15 | N/A | 17 | N/A |
3/31/2015 | 366 | -20 | N/A | 18 | N/A |
12/31/2014 | 367 | -20 | N/A | 4 | N/A |
9/30/2014 | 362 | 71 | N/A | 3 | N/A |
6/30/2014 | 365 | 55 | N/A | -6 | N/A |
3/31/2014 | 355 | 52 | N/A | 20 | N/A |
12/31/2013 | 349 | 32 | N/A | 33 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: DEXP4's forecast earnings growth (5.4% per year) is below the savings rate (10.1%).
Winst versus markt: DEXP4's earnings (5.4% per year) are forecast to grow slower than the BR market (13.1% per year).
Hoge groeiwinsten: DEXP4's earnings are forecast to grow, but not significantly.
Omzet versus markt: DEXP4's revenue (14.6% per year) is forecast to grow faster than the BR market (7.5% per year).
Hoge groei-inkomsten: DEXP4's revenue (14.6% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if DEXP4's Return on Equity is forecast to be high in 3 years time